Potential cure for hepatitis B enters phase 1/2a clinical trial

(Walter and Eliza Hall Institute) A new treatment developed by Walter and Eliza Hall Institute researchers to promote the cure of chronic hepatitis B virus infection is now recruiting patients for a phase I/2a clinical trial.